R2 Technologies expands Glacial Skin with new global collaborations

R2 Technologies said new commercial, clinical and skincare collaborations are helping expand adoption of its Glacial Skin platform in the U.S. and overseas. The moves include work with Huadong Medicine, VIO Med Spa and several skincare brands as the company builds out education, practice support and treatment protocols.

Why it matters: - R2 Technologies is trying to turn Glacial Skin from a device into a broader treatment ecosystem across medical aesthetics. - The collaborations are designed to widen access, support provider education and make the platform easier to adopt in clinics and med spas. - R2 is targeting both U.S. growth and international expansion, including China and other strategic markets.

What happened: - R2 Technologies announced several strategic collaborations supporting the continued expansion of Glacial Skin. - The company said the collaborations cover international commercialization, multi-location medical spa adoption, physician education and skincare protocol development. - The announcement was made in Q2 2026. - R2 Technologies is headquartered in Dublin, Calif.

The details: - R2 continues to work with Huadong Medicine to support commercial development for Glacial Skin in China and other strategic international markets. - R2 is collaborating with VIO Med Spa, a U.S. network with more than 60 locations, to integrate Glacial Skin into a multi-location practice model. - VIO Med Spa was recently named Entrepreneur Magazine’s Franchise 500 #1 Med Spa Franchise for three consecutive years. - Glacial Skin is supported by scientific founders and physicians including Dr. Rox Anderson, Dr. Dieter Manstein, Dr. Henry Chan, Dr. Paul Friedman and Dr. Taryn Murray. - R2 has also expanded engagement with physicians, educators, innovators and practitioners including Dr. Barry DiBernardo, Dr. Jason Pozner, Dr. Alan Durkin, Dr. Chris Robb, Dr. Farid Kazem, Dr. Christine Dierickx, Dr. Karla Limon, Sarah Hamilton, RN, Erika Barry, RN, and Savanna Boda. - The broader network of Glacialist Ambassadors supports clinical education, practice development and best-practice sharing. - R2 is introducing Glacial Gloss Signature Collection Protocols in 2026. - The protocols pair Glacial Skin’s temperature-controlled technology with topical skincare regimens. - Initial skincare collaborations include Face Reality Skincare, Senté and Renée Rouleau Professional Skin Care. - R2 is also launching a dedicated East Asia Glacial Gloss Signature protocol focused on luminosity and skin tone appearance. - R2 says the protocols are intended to help providers personalize treatment workflows for visible redness, acne-related irritation and overall skin luminosity. - The company says the Glacial Gloss framework gives practices a structured, repeatable approach with minimal disruption to patients’ daily routines. - R2 said Glacial Skin is a non-invasive skin treatment solution built on CryoAesthetics technology.

Between the lines: - R2 is signaling that product adoption alone is not enough; the company is building distribution, clinical credibility and adjacent skincare partnerships at the same time. - The emphasis on protocols and education suggests R2 wants Glacial Skin to fit into everyday practice workflows, not just stand as a standalone device. - The mix of U.S. spa expansion and international commercialization points to a market strategy built around scalable channels rather than one-off placements.

What's next: - R2 plans to continue supporting commercial development in China and other international markets through its Huadong Medicine collaboration. - The company will keep expanding provider education and practice support around Glacial Skin. - R2 is expected to roll out Glacial Gloss Signature Collection Protocols during 2026. - More information is available at the company's announcement and on R2 Technologies' LinkedIn, Instagram, Facebook, YouTube and TikTok.

The bottom line: - R2 is betting that Glacial Skin’s next stage of growth will come from partnerships, protocols and provider networks as much as from the technology itself.